|
市場調查報告書
微RNA診斷・治療市場及癌症個人化醫療市場：2009年
MicroRNA Diagnostics, Therapeutics, and Cancer Personalized Medicine 2009 Market Report
|
微RNA診斷・治療市場及癌症個人化醫療市場：2009年 是由出版商Select Biosciences, Ltd.在2009年07月所出版的。
這份英文市場調查報告書包含196 pages 價格從美金2510起跳。
本報告書內容包括：微RNA（miRNA）診斷・治療市場及癌症個人化醫療市場詳細調查分析、癌症個人化醫療領域的技術概要、技術開發動向、市場規模、產品領域別收益預測、各種技術的市場滲透率、新的微RNA診斷・治療領域的技術動向、市場環境、主要企業介紹等。內容綱要摘記如下：
第1章 實施概要
- 調查範圍
- 個人化醫療的市場區隔
- 廣泛個人化醫療產業環境
- 個人化醫療的定量市場矩陣
第2章 個人化醫療：技術環境
- 個人化醫療的定義
- 個人化醫療的成長
- 臨床現場個人化醫療的實例及活體内作用機制的詳細介紹
- 附帶診斷之共同治療的銷售額成長
- 美國FDA：刺激市場採用個人化醫療的因素
- 個人化醫療的新動向及主題
第3章 癌症個人化醫療市場：市場環境
- 癌症診斷/治療：主要市售產品的市場環境
- 乳癌臨床病情的預測因素：利用多重基因的乳癌臨床病情市售預測產品
- 其他癌症的個人化醫療・新的癌症個人化醫療領域環境
- 針對急性骨髓性白血病（AML：Acute Myeloid Leukemia）的FLT3
- 口服抗凝固治療（warfarin）的個人化醫療
- 癌症的個人化醫療：全球主要市場的市場調查資料
- 根據個人化醫療領域的市場區隔
- 癌症個人化醫療的市場區隔
- 更廣泛的個人化醫療的市場區隔：疾病・治療區隔別
- 癌症個人化醫療的市場區隔：癌症類型別
- 市場區隔：生物標記類型別
- 市場區隔：微RNA・外遺傳變化別
- 現在應用於個人化醫療的技術的市場滲透率
- 現在各種診斷平台的個人化醫療滲透率
- 個人化醫療檢查：刺激市場利用的因素及課題
第4章 微RNA診斷・治療：技術及市場環境
- 微RNA市場的現況
- 微RNA調節不全與疾病惡化間的關聯性
- 利用微RNA的癌症地圖
- 與人類癌症相關的微RNA
- 與癌症以外疾病相關的微RNA
- 微RNA作用的發病路徑
- 控制癌症相關基因的微RNA
- 微RNA的多態性(Polymorphism)
- 做為診斷・治療藥的微RNA的開發：市場分析
- 新進入市場企業：主要微RNA診斷・治療相關企業
- 產業昇級：開發中的微RNA治療藥
- 產業昇級：微RNA診斷・治療領域的里程碑
附錄I：調查方法
附錄II：個人化醫療的法規指南
附錄III：利用藥物代謝促進有效性及毒性
Abstract
This is the latest and most up-to-date Market Analysis Report from Select
Biosciences addressing MicroRNA Diagnostics, Therapeutics and Cancer
Personalized Medicine. The Cancer Personalized Medicine Marketplace Provides a
Paradigm for the development of MicroRNA Diagnostics and Therapeutics and this
Market Report brings together these Emerging Disciplines. This comprehensive
report provides a thorough discussion and analysis of the cancer personalized
medicine space and from both a technical as well as market-focused
perspective. Cancer Personalized Medicine represents the leading-edge of the
broader Personalized Medicine Marketplace and Select Biosciences maps the
qualitative and quantitative market trends and metrics in this report
(including market segmentation, market sizing, growth rates, revenue
projections broken-out by product areas, and market penetration of various
technologies in cancer personalized medicine). Analysis of the cancer
personalized medicine space through bottom-up analysis, via detailed market
surveys administered by Select Biosciences to a worldwide industry participant
pool, are presented in this report. Commercial and competitive landscape of
the emerging microRNA diagnostics/therapeutics marketplace are presented in
the context of the leading edge of this space - cancer.
Extensive Worldwide Technical and Market Analyses Presented in this Report:
- Technical aspects of the Broader Personalized Medicine Space as well as
Cancer Personalized Medicine
- Current products in the Cancer Personalized Medicine Space: Their
mechanisms of action, projected revenues, competitive position and
benchmarking, with emphasis on Breast Cancer Personalized Medicine
- Segmentation of the Broader Personalized Medicine Marketplace by
Therapeutic/Disease Area Addressed Currently
- Segmentation of the Cancer Personalized Medicine Market by Types of Cancer
Addressed Currently
- Results and Analyses from Select Biosciences recent worldwide market
surveys focusing upon the qualitative and quantitative trends in Cancer
Personalized Medicine. Areas of coverage include the market penetrance of
various technologies used industry-wide, distribution of the industry with
respect to types of biomarkers studied, penetrance of diagnostic platforms,
and drivers/challenges to market adoption
- MicroRNAs identified with association with specific diseases
- MicroRNA-based Personalized Medicine
- MicroRNA Diagnostics/Therapeutics Industry Trends and Milestones
- MicroRNA Diagnostics/Therapeutics Competitive Landscape
- More details of the scope of coverage of this industry report are found in
the Table of Contents (TOC) for the report - see below for link to
downloadable PDF of the TOC
Table of Contents
Chapter I . Executive Summary
- Scope
- Personalized Medicine Market Segmentation
- The Broader Personalized Medicine Industry Landscape: Selected Therapies,
Biomarkers, and Indications
- Personalized Medicine: Quantitative Market Metrics (market size, product
class projected revenues, growth rate)
Chapter II . Personalized Medicine: Technology Landscape
- Definition of Personalized Medicine
- Growth of Personalized Medicine
- Examples of Personalized Medicine in Clinical Practice together with
Details of Mechanism of Action in vivo
- Companion Diagnostics drive Companion Therapeutics Sales
- The US FDA is a Driver for Personalized Medicine Market Adoption
- Emerging Trends and Themes in Personalized Medicine
Chapter III . Cancer Personalized Medicine Market Landscape
- [a]. Coupled Diagnostics/Therapeutics for Cancer - The Market Landscape of
the Major Commercial Products
- [b]. Predictors of Clinical Outcome in Breast Cancer Commercialized
Multigene Predictors of Clinical Outcome for Breast Cancer
- [c]. Personalized Medicine in Other Cancers and the Landscape of the
Emerging Cancer Personalized Medicine Space FLT3 for Acute Myeloid Leukemia
(AML)
- [d]. Personalized Medicine in Oral Anticoagulant (warfarin) Therapy
- [e]. Cancer Personalized Medicine Worldwide Primary Market Survey Data
- Respondent Pool Characterization
- Segmentation based on Type of Areas in Personalized Medicine
- Cancer Personalized Medicine Market Segmentation
- Segmentation of the Broader Personalized Medicine Marketplace by
- Therapeutic/Disease Areas Addressed Currently
- Segmentation of the Cancer Personalized Medicine Space by Types of Cancer
- Focused upon Currently
- Market Segmentation by Types of Biomarkers Studied Currently
- Segmentation of the Personalized Medicine Marketplace by Study of
microRNAs, Epigenetic Changes
- Market Penetrance of Technologies Currently Utilized in Personalized
Medicine
- Current Penetrance of Various Diagnostic Platforms into Personalized
Medicine
- Personalized Medicine Tests: Drivers and Challenges in Market Adoption
Chapter IV. MicroRNA Diagnostics and Therapeutics: Technology and Market Landscape
- Current Status of the MicroRNA Marketplace
- MicroRNA Dysregulation is Associated/Linked with Disease Processes
(primarily cancer)
- MicroRNA Cancer Mapping
- MicroRNAs that are Associated with Human Cancers
- MicroRNAs Associated with Diseases Other than Cancer
- Developmental Pathways Regulated by MicroRNAs
- MicroRNAs Regulating Cancer-related Genes
- MicroRNA Polymorphisms
- Deployment of MicroRNAs as Diagnostics and Therapeutics: Market Analysis
- Emerging Market Participants: Selected MicroRNA Diagnostics and
- Therapeutics-focused Companies (Company Profiles: Areas of Focus, Business
Models)
- Industry Update: MicroRNA Therapeutics in Development
- Industry Update: Milestones of Note in the MicroRNA Diagnostics and
Therapeutics Space
Appendix I. Research Methodology
Appendix II. Regulatory Guidelines in Personalized Medicine
Appendix III. Drug Metabolism Drives Efficacy and Toxicity
|
